Metabolium has a new Chief Operating Officer

Dr Khadidja Romari takes up the position

French biotechnology company Metabolium has appointed Dr Khadidja Romari as Chief Operating Officer and Chief Scientific Director.

Before joining the company, Romari spent several months as scientific advisor to Dominique Duvauchelle, CEO of Metabolium, to gain an understanding of the company's technologies. Her new role will focus on developing the product portfolio and raising the company's international profile to secure new partnerships.

Romari has more than 20 years’ experience in product development in the aquaculture, dietary supplements, cosmetic and pharmaceutical industries. Her expertise is in isolating, cultivating and valorising cyanobacteria, microalgae, mushrooms, and bacteria originating from varied environments.

Before joining Metabolium, Romari helped to develop American companies such as Bigelow Laboratory for Ocean Sciences, Albany Molecular Research and Targeted Growth. Since returning to France in 2010 she has led scientific and technical development at Fermentalg and then at Greensea.

You may also like

Packaging

Innovating primary packaging for parenteral drugs: challenges and future directions

The new challenges brought about by the pandemic call for an increasingly scientific approach to the evolution of single packaging elements in order to anticipate the needs of new drug formulations and guarantee a more enhanced, measurable and stable level of performance
Regulatory

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Hybrid interferons: developing a novel drug class

With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These challenges can be further amplified if the candidate being developed is of an entirely novel drug class
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Manufacturing

Anton Paar expands Litesizer DIA Series with new models

Introducing affordable and advanced solutions for particle analysis
Manufacturing

Triple your efficiency with the new DrySyn Vortex

Boost productivity with temperature-controlled parallel reactions
Subscribe now